Press-release for stocks related to approval for amyt

Prices are updated after-hours

Amryt Receives Reimbursement Approval from the Dutch Ministry of Health for Myalepta® (metreleptin)
Published: 2022-10-17 (Crawled : 12:20) - biospace.com/
AMYT | News | $14.7 0.0% 2.4M

| 115.66% | O: -0.15% H: 4.05% C: 2.56%
myalepta health approval

Amryt Receives Marketing Authorisation Approval and Orphan Drug Designation for Filsuvez® in Great Britain
Published: 2022-09-08 (Crawled : 18:00) - biospace.com/
AMYT | News | $14.7 0.0% 2.4M

| 88.02% | O: 1.93% H: 0.0% C: -1.38%
filsuvez designation drug approval

| 6.27% | O: 1.45% H: 8.29% C: 1.43%
approval health

Amryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
Published: 2021-01-20 (Crawled : 07:03) - globenewswire.com
AMYT | News | $14.7 0.0% 2.4M

| 7.12% | O: 2.99% H: 1.56% C: 0.0%
approval

Amryt Receives Ministry of Health Reimbursement Approval for Lojuxta® (lomitapide) in Saudi Arabia
Published: 2020-12-17 (Crawled : 07:01) - globenewswire.com
AMYT | News | $14.7 0.0% 2.4M

| 10.85% | O: -1.28% H: 2.37% C: 2.37%
approval health

Amryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil
Published: 2020-12-09 (Crawled : 07:00) - globenewswire.com
AMYT | News | $14.7 0.0% 2.4M

| 9.85% | O: 4.87% H: 0.0% C: -1.79%
brazil approval

65%

35%

CSSE 4 | $0.4323 183.85% 64.77% 210M

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.45 12.5% 30.92% 320K

MULN | News | $3.78 38.46% 27.78% 13M

RILY | $29.86 37.48% 27.26% 12M

Save your searches and get alerts when important news are released.